Lionsgate Studios Corp Common Shares vs UnitedHealth Group Inc — how do they compare? Lionsgate Studios Corp Common Shares trades at $10.86 (market cap $3.24B), while UnitedHealth Group Inc trades at $397.69 (market cap $355.11B). The key difference: UnitedHealth Group Inc is far larger — about 109.6× Lionsgate Studios Corp Common Shares's market cap, and UnitedHealth Group Inc pays a 2.35% dividend while Lionsgate Studios Corp Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lionsgate Studios Corp Common Shares for 0 Days and UnitedHealth Group Inc for 98 Days on average.
| LION | UNH | |
|---|---|---|
Market Cap | $3.24B | $355.11B |
Volume | 3,214,595 | 7,759,080 |
Sector | Technology | Health |
52-Week High | $16.40 | $436.35 |
52-Week Low | $5.91 | $259.02 |
Typical Hold Time | 0 Days | 98 Days |
Enterprise Value | $6.75B | $396.97B |
Dividend Yield | — | 2.35% |
Signals from Pluang's Aura AI — not financial advice
LION trades at $11.12, up 0.36% on the day, with a market cap of approximately $1.3 billion. The stock shows mixed signals: strong analyst support (87.5% buy rating) and a consensus price target of $16.80 suggest upside, but negative net income and shareholder equity highlight financial strain. Recent Q1 2027 earnings beat estimates with EPS of $0.37, yet the company remains unprofitable with a net loss of $128.5 million in 2025. Takeover interest from firms like Bolloré adds speculative appeal.
The outlook hinges on operational turnaround and potential M&A. Revenue growth from hit films like 'Michael' and a valuable content library offer catalysts, but high debt ($3.65B total) and consistent losses pose significant risks. Investors should weigh the 51% upside to price targets against fundamental weaknesses and industry volatility.
UnitedHealth Group (UNH) trades at $377.76, down 0.2% on the day, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $6.38 surpassing the $4.91 expectation. Revenue reached $447.57 billion in 2025, though net income margin declined to 2.69%. Recent news highlights dividend payments and strategic moves like the TPG deal for WellMed clinics.
UNH presents a favorable outlook with a consensus price target of $470.11, implying significant upside. Strengths include robust cash flow, a dominant market position, and AI investments in Optum. Risks involve regulatory pressures, rising medical costs, and debt levels. The stock remains a core holding for growth-oriented investors seeking healthcare exposure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lionsgate Studios Corp. is a standalone content company that develops, finances, produces, and distributes motion pictures and television series, licensing its content to theaters, streaming platforms, television networks, and home entertainment channels.
Read more on LION →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →